# Lonza to invest €18 million in API centre expansion in Nansha, China

Lonza is investing around €18 million in GMP laboratories and mid-scale manufacturing at its API centre in Nansha, China, adding six 1,000-litre and four 1,500-litre reactors, due onstream between Q1 and Q3 2022.

- Type: Expansion
- Announced: 2021-06-30
- Where: Nansha, China, China
- Value: $21.0M (18.0M EUR)
- Starts operating: Q1 2022
- Status: announced
- Products: active pharmaceutical ingredients (APIs), HPAPIs
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Lonza Group AG](https://endata.com/companies/20735.md)

## Sources

- [viewer.joomag.com](https://viewer.joomag.com/speciality-chemicals-magazine-jul-aug-2021/0261349001624950868/p10), 2021-06-30: "Lonza is to invest around € 18 million in GMP laboratories and mid-scale manufacturing at its API centre in Nansha, China."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.